There is no single universally recommended dose of DHEA for menopausal women because the answer depends entirely on what you are trying to treat. The clearest evidence supports intravaginal DHEA at a low dose of about 6.5 mg daily for vaginal dryness and related symptoms, and this is the only form that has received regulatory approval. For oral DHEA supplements, studies typically use 25 to 50 mg per day, but the Endocrine Society explicitly recommends against routine oral use due to limited proof of benefit and concerns about side effects. The gap between what’s sold over the counter and what the science actually supports is wide enough that it deserves a close look.
Why DHEA Declines After Menopause
Your adrenal glands produce DHEA and its sulfate form throughout life, but output starts falling in your thirties and accelerates around menopause. By the time a woman reaches her sixties or seventies, circulating DHEA can drop to roughly 10 to 20 percent of the levels found in young adults.1PubMed Central. A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? This decline matters because DHEA serves as a raw material that your body’s cells convert into small amounts of estrogen and testosterone locally, right where they are needed. After menopause, when the ovaries are no longer the main hormone source, the conversion of DHEA inside individual tissues becomes one of the few remaining routes for producing sex hormones at the cellular level.2PubMed. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology
That biological logic is what makes DHEA supplementation appealing in theory: if the raw material is low, topping it off should let the body make the hormones it needs. In practice, though, swallowing a pill of DHEA does not neatly replicate what young adrenal glands do, and the downstream effects on hormones vary a lot from woman to woman.
Intravaginal DHEA for Vaginal Dryness and Pain
The strongest clinical evidence for DHEA in menopausal women is not for an oral supplement at all. It is for a vaginal insert containing 0.50% DHEA (about 6.5 mg), applied daily. In large trials, 12 weeks of this treatment reduced vaginal dryness and pain during sex, lowered vaginal pH, and improved the health of vaginal tissue by measures like cell composition and tissue thickness. The improvements over placebo were statistically clear across multiple endpoints.3PubMed. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause This product is marketed as prasterone under the brand name Intrarosa and is the only DHEA formulation that has gone through the full regulatory approval process.
What makes the vaginal route attractive is that the DHEA stays local. It gets converted into estrogen and testosterone inside vaginal tissue cells, where those hormones do their work, and then gets broken down before entering the bloodstream in any meaningful way. Studies measuring blood levels after intravaginal use have confirmed that serum estradiol and testosterone remain within the normal postmenopausal range even at the highest tested doses.4PubMed. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women That local-only action is an important safety feature, because it avoids the systemic hormone exposure that raises concerns with traditional estrogen therapy.5PubMed. Intravaginal DHEA provides local action without systemic effects
For women dealing with vaginal dryness, painful intercourse, or recurrent urinary symptoms related to menopause, this is the form of DHEA with genuine evidence behind it. A clinical review of available options concluded that intravaginal DHEA improves symptoms, signs, and quality of life while remaining safe because of its specific local effect.6PubMed Central. Treatment of genitourinary syndrome of menopause: the potential effects of intravaginal ultralow-concentration oestriol and intravaginal dehydroepiandrosterone on quality of life and sexual function
Oral DHEA at 25 mg Versus 50 mg
Most clinical trials of oral DHEA in postmenopausal women have used doses in the 25 to 50 mg per day range. The hormonal effects of those two doses are not the same, and a 2025 meta-analysis of randomized controlled trials drew a sharp line between them. Doses of 50 mg or more per day produced a clear rise in both testosterone and estradiol levels. Doses below 50 mg did not produce a statistically significant change in either hormone.7PubMed Central. Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects
That does not mean 25 mg does nothing. One study that followed both early and late postmenopausal women taking 25 mg daily found increases in androgens, estrogens, and the neurosteroid allopregnanolone, along with reduced climacteric symptoms. The researchers compared its endocrine effects favorably to conventional hormone therapy.8PubMed. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids But across the larger body of evidence, the 25 mg dose is more subtle in its effects, and it is the 50 mg dose that consistently moves blood hormone levels into a detectable range.
Higher doses have also been tested. One early study used 1,600 mg daily, split into two 400 mg doses, and saw massive spikes in androgens within hours, with testosterone rising roughly ninefold by two weeks.9The Journal of Clinical Endocrinology & Metabolism. The Effects of Oral Dehydroepiandrosterone on Endocrine-Metabolic Parameters in Postmenopausal Women That kind of supraphysiological dosing is not considered safe or appropriate for routine use, but the study illustrates how dramatically DHEA can shift the hormonal landscape when taken in large amounts.
What Oral DHEA Does Not Reliably Improve
The most common reasons women consider DHEA supplements are hot flashes, mood problems, low libido, and general wellbeing. The evidence for all of these is disappointing. A Cochrane systematic review looking at DHEA in peri- and postmenopausal women found the results from trials were inconsistent and could not easily be combined to produce a clear overall effect on menopausal symptoms.10PubMed Central. Dehydroepiandrosterone for women in the peri- or postmenopausal phase
Sexual function has been studied repeatedly with similarly weak results. A review of randomized controlled trials found that the evidence was limited by small sample sizes and short treatment periods, with inconsistent outcomes for libido and wellbeing.11PubMed. DHEA therapy for women: effect on sexual function and wellbeing A dedicated trial giving postmenopausal women with low sexual desire 50 mg of DHEA daily for six months found no significant improvements in sexual function compared to placebo.12PubMed. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido
Cognition is another area where the hopes have run ahead of the data. Several trials have tested whether DHEA protects against age-related cognitive decline. One found that DHEA seemed to prevent stress-related deterioration in selective attention, but the same trial saw impaired visual memory recall in the DHEA group. A year-long trial in 225 healthy older adults showed no cognitive benefit at all. A Cochrane meta-analysis of five validated studies concluded there were no consistent effects on cognitive outcomes.13The Journal of Clinical Endocrinology & Metabolism. Should Dehydroepiandrosterone Be Administered to Women? – Section: DHEA Therapy in DHEA Nondeficient States There is some research suggesting that DHEA levels correlate with memory circuit function specifically in postmenopausal women who have major depression, but this is observational and does not show that supplementation helps.14PubMed Central. Impact of adrenal hormones, reproductive aging, and major depression on memory circuitry decline in early midlife
The Bone Density Signal
One area where oral DHEA shows more promise is bone health, though the evidence is still modest. A pooled analysis of four clinical trials found that women taking 50 mg of DHEA daily had about a one percent increase in lumbar spine bone mineral density and a half-percent increase at the hip trochanter, while maintaining total hip density. Interestingly, men in the same analysis showed no bone benefit.15PubMed Central. Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials A separate trial reported increases of about 1.6 percent in total body and 2.5 percent in lumbar spine bone density with DHEA replacement.16PubMed. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men
Genetic evidence adds some weight to this finding. A Mendelian randomization study, which uses genetic variants as natural experiments, found that higher genetically predicted DHEA-S levels were linked to greater lumbar spine bone density and fewer forearm fractures in women.17The Journal of Clinical Endocrinology & Metabolism. Endogenous DHEAS Is Causally Linked With Lumbar Spine Bone Mineral Density and Forearm Fractures in Women These bone effects are real but small, and no trial has been large enough or long enough to show that DHEA supplementation actually prevents fractures. Standard osteoporosis treatments remain far better supported.
What Medical Societies Recommend
Despite decades of research, the Endocrine Society’s clinical practice guideline on androgen therapy in women recommends against the routine use of DHEA, citing limited data on both effectiveness and safety.18The Journal of Clinical Endocrinology & Metabolism. Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline An earlier Endocrine Society guideline noted that DHEA is technically a prohormone, not a true androgen, since it does not directly activate the androgen receptor. Instead it gets converted into various end products, some estrogenic and some androgenic, making its tissue-level effects unpredictable.19The Journal of Clinical Endocrinology & Metabolism. Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
A 2022 clinical review in the same journal summarized the state of affairs plainly: no consistent beneficial effects of oral DHEA have been observed for menopausal symptoms, sexual function, cognition, or overall wellbeing in normal women. The only exception is local administration for vulvovaginal atrophy. Risks of prolonged use at high physiologic or pharmacologic doses include androgenic and estrogenic side effects that raise concerns about long-term safety.20PubMed Central. Approach to the Patient: Should Dehydroepiandrosterone Be Administered to Women?
Side Effects to Watch For
The most common side effects of oral DHEA are androgenic, meaning they stem from the testosterone and related hormones your body makes from DHEA. These include increased oil production in the skin, acne, and unwanted hair growth on the face or body. These effects tend to be dose-dependent, becoming more likely at 50 mg and above.21PubMed. DHEA: why, when, and how much–DHEA replacement in adrenal insufficiency A meta-analysis of trials in postmenopausal women confirmed that DHEA increased androgenic side effects compared to placebo or no treatment, without improving quality of life, menopausal symptoms, or sexual function enough to offset those effects.22The Journal of Clinical Endocrinology & Metabolism. Should Dehydroepiandrosterone Be Administered to Women? – Section: Adverse Effects of DHEA Administration to Women
The concern about breast cancer is more nuanced. Laboratory studies have shown that DHEA can either inhibit or stimulate breast cancer cell growth depending on the estrogen environment. When estrogen levels are high, DHEA tends to inhibit mammary cancer growth, but in a low-estrogen setting, which is exactly the situation after menopause, it can stimulate growth. Epidemiological studies have reported a positive correlation between higher DHEA levels and increased breast cancer risk in postmenopausal women specifically.23PubMed. Dietary supplements of dehydroepiandrosterone in relation to breast cancer risk This does not mean DHEA supplements cause breast cancer, but it is a signal that long-term use deserves caution, particularly in women with a personal or family history of the disease. A small retrospective study of cancer survivors using vaginal DHEA for six months found no cancer recurrence and no concerning changes in endometrial thickness, but the follow-up was short and the sample was small.24PubMed Central. Treatment of Genitourinary Syndrome of Menopause in Breast Cancer and Gynecologic Cancer Survivors: Retrospective Analysis of Efficacy and Safety of Vaginal Estriol, Vaginal Dehydroepiandrosterone and Ospemifene
The Supplement Quality Problem
In the United States, DHEA is classified as a dietary supplement rather than a drug, which means manufacturers do not have to prove safety or effectiveness before selling it. Products do not need to meet the same manufacturing and quality control standards that apply to approved medications.25JAMA. Quality Control of Dehydroepiandrosterone Dietary Supplement Products Independent testing has repeatedly found that DHEA supplements vary in what they actually contain, with some pills delivering significantly more or less than the label says. If you are aiming for a specific dose, that variability alone can throw off your results.
This matters practically. If a study finds that 50 mg per day raises testosterone by a certain amount, but the capsule you buy contains 35 mg or 70 mg of actual DHEA, your hormonal response will not match the study’s findings. Anyone choosing to use oral DHEA should look for brands that have been independently tested by a third-party certification program.
Why Responses Vary So Much Between Women
One reason DHEA trials produce inconsistent results is that individual women metabolize it very differently. Your body uses a series of enzymes to convert DHEA into downstream hormones, and genetic variation in those enzymes affects how much testosterone, estradiol, or other products you end up making from a given dose. Research on women going through the menopausal transition found that variants in sulfotransferase genes were associated with meaningfully different levels of DHEA-S, estradiol, and testosterone over time.26PubMed Central. Effect of hormone metabolism genotypes on steroid hormone levels and menopausal symptoms in a prospective population-based cohort of women experiencing the menopausal transition Similar genetic variation has been shown to influence how women respond to conventional hormone therapy as well.27PubMed Central. Influence of SULT1A1 genetic variation on age at menopause, estrogen levels, and response to hormone therapy in recently postmenopausal white women
This variability means that even if you take the “right” dose based on what worked in a clinical trial, your body might convert more of that DHEA into testosterone than average, giving you acne and facial hair, or it might convert more into estrogen, or it might do relatively little with it at all. There is no practical genetic test available to guide DHEA dosing for individual women. In the absence of such personalization, the safest approach, if you use oral DHEA at all, is to start at the lower end of the studied range and have your hormone levels checked after a few weeks.
How DHEA Compares to Standard Hormone Therapy
Some women are drawn to DHEA because it feels more “natural” than conventional hormone replacement therapy, or because it is available without a prescription. But the hormonal profiles produced by DHEA and HRT are not interchangeable. A year-long study comparing 10 mg daily DHEA to standard HRT found that DHEA produced a significant rise in androgens that HRT did not, while HRT produced a larger rise in estrogens and beta-endorphin than DHEA did.28PubMed. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu In other words, DHEA pushes the hormonal balance toward androgens, while conventional HRT pushes it toward estrogens. They are not doing the same thing.
A review published in the British Menopause Society Journal pointed out that despite early enthusiasm, there have been very few well-designed randomized, placebo-controlled trials of DHEA for menopausal symptoms, and the clinical evidence does not support using it as an alternative to standard HRT.29British Menopause Society Journal. DHEA and the menopause: a new approach to HRT? For women whose primary complaints are hot flashes, night sweats, and mood disruption, conventional hormone therapy has far more evidence behind it. DHEA occupies a different niche: it can help with vaginal symptoms when used locally, and it may have a role in preserving bone density, but it is not a substitute for estrogen replacement in managing classic menopausal symptoms.
Insulin Sensitivity and Inflammation
A less well-known area of DHEA research involves metabolic health. A preliminary study found that six months of DHEA replacement improved insulin action in elderly participants, improved glucose tolerance in those who started with abnormal values, and reduced triglycerides and the inflammatory markers IL-6 and TNF-alpha.30PubMed Central. Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans These findings are intriguing, but they come from small, short-term studies and have not been confirmed in larger trials. They are worth mentioning because they hint at mechanisms through which DHEA might affect cardiovascular and metabolic risk, but no medical organization recommends DHEA supplementation for diabetes prevention or metabolic health based on current evidence.
For a menopausal woman weighing whether to try DHEA, the practical picture is this: if your concern is vaginal dryness or painful sex, ask your doctor about the prescription vaginal insert, which works well and stays local. If you are considering an over-the-counter oral supplement for general wellbeing, hot flashes, or mood, the evidence does not back it up, and you are more likely to notice androgenic side effects than symptom relief. And if you do decide to try oral DHEA, 25 mg daily is the lowest commonly studied dose and the most cautious starting point, with blood work to monitor what your body is actually doing with it.